Improving the Performance of Prenatal Cell‐Free DNA Screening Through Size‐Selective Fetal DNA Enrichment in a Cohort of 71,986 General and High‐Risk Pregnancies
Prenatal Diagnosis · 2025
DOI: 10.1002/pd.6775 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prenatal Diagnosis, 2025. Verfasst von Liang Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory, Longgang District Maternity & Child Healthcare Hospital of Shenzhen City (Longgang Maternity and Child Institute of Shantou Unive…. Hauptthemen laut MEDLINE: Cell-Free Nucleic Acids, Noninvasive Prenatal Testing, Pregnancy, High-Risk, Prenatal Diagnosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Natural Science Foundation of Shenzhen Municipality, the Medical and Health Technology Research Project, Special Funds for Science and Technology, Innovation Longgang District of Shenzhen City.
Abstract (Originalsprache)
Objective
To evaluate the performance of prenatal cell‐free DNA (cfDNA) screening with and without the cell‐free fetal DNA enrichment method in general‐risk and high‐risk pregnancies.
Methods
We performed a size‐selective cell‐free fetal DNA enrichment in 71,986 pregnancies. The cfDNA screening and follow‐up results were collected for trisomies 21, 18, 13, fetal sex chromosome abnormalities (SCAs), and copy number variants (CNVs). The fetal fraction of cfDNA, positive rates, and positive predictive values (PPV) were compared between the general‐risk and high‐risk pregnancies with and without enrichment.
Results
With the cell‐free fetal DNA enrichment, the fetal fraction of cfDNA increased to 18.87 ± 5.94. The overall PPVs for common trisomies increased to 88.46% and 91.11% in the general‐ and high‐risk populations, respectively. For CNVs, the PPVs with enrichment increased to 53.52% and 66.67% in the general risk and high‐risk populations, respectively. However, for SCAs, the PPV was not improved by cell‐free fetal DNA enrichment. The failure rates in the general‐risk and high‐risk groups decreased to 0.01% and 0.08%.
Conclusions
Cell‐free fetal DNA enrichment significantly improves the PPVs of common trisomies and CNVs in general and high‐risk populations. It has the potential for the clinical application effect of cell‐free DNA screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Central Laboratory, Longgang District Maternity & Child Healthcare Hospital of Shenzhen City (Longgang Maternity and Child Institute of Shantou University Medical College), Shenzhen, China.
- Longgang District Key Laboratory for Birth Defects Prevention, Shenzhen, China.
ORCID-Profile: Liang Hu, Lijuan Wen, Weiqiang Liu
Förderung
- Natural Science Foundation of Shenzhen Municipality
- the Medical and Health Technology Research Project, Special Funds for Science and Technology, Innovation Longgang District of Shenzhen City
Zitieren
APA
Hu, L., Wen, L., Liu, Y., Chen, X., Zhong, J., Liu, W., & Wei, F. (2025). Improving the Performance of Prenatal Cell‐Free DNA Screening Through Size‐Selective Fetal DNA Enrichment in a Cohort of 71,986 General and High‐Risk Pregnancies. Prenatal Diagnosis. https://doi.org/10.1002/pd.6775
Vancouver
Hu L, Wen L, Liu Y, Chen X, Zhong J, Liu W, et al. Improving the Performance of Prenatal Cell‐Free DNA Screening Through Size‐Selective Fetal DNA Enrichment in a Cohort of 71,986 General and High‐Risk Pregnancies. Prenatal Diagnosis. 2025. doi:10.1002/pd.6775
BibTeX
@article{Hu2025,
author = {Hu, Liang and Wen, Lijuan and Liu, Yanan and Chen, Xiaohang and Zhong, Jiatong and Liu, Weiqiang and Wei, Fengxiang},
title = {Improving the Performance of Prenatal Cell‐Free DNA Screening Through Size‐Selective Fetal DNA Enrichment in a Cohort of 71,986 General and High‐Risk Pregnancies},
journal = {Prenatal Diagnosis},
year = {2025},
doi = {10.1002/pd.6775}
}
EUVIMED